English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16812/19099 (88%)
Visitors : 6405607      Online Users : 326
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/21258


    標題: Flunitrazepam生物共軛物之合成及其多株抗體之生產
    Studies on the Synthesis of Flunitrazepam-Protein Bioconjugate and Production of Polyclonal Antibodies against Flunitrazepam
    作者: 周淑芬
    黃國旭
    周欣彥
    苗林森
    楊朝成
    貢獻者: 生物科技系
    化妝品科技研究所
    關鍵字: FM2
    生物共軛物
    多株抗體
    酵素連結免疫吸附分析法
    Flunitrazeparn
    Bioconjugate
    Polyclonal antibodies
    Enzyme-linked immunosorbent assay ( ELISA )
    日期: 2008
    上傳時間: 2009-05-04 15:35:30 (UTC+8)
    摘要: 本研究之目的在於自行合成flunitrazepam (FM2)與蛋白質之生物共軛物(bioconjugates)並以其為免疫原來腹腔免疫ICR小鼠以生產FM2 之多株抗體(polyclonal antibodies against, FM2; anti-FM2 PAbs)。由於FM2 分子量小(約313.3g/mol),不易在小鼠體內引起免疫反應,故本研究選用牛血清白蛋白(bovine serum albumin BSA)以及絲膠蛋白(Sericin ; Ser),分別與FM2合成生物共軛物,藉由大分子蛋白誘導小鼠體內產生FM2 之抗體。多株抗體製作過程為將高度免疫(hyperimmune)之ICR小鼠,注射0.5mL Pristane後,再問隔兩週注射106個Ns-l 骨髓癌細胞。待小鼠腹腔漲大至行動困難時,收集ICR小鼠所產生之腹水及血清,利用HitrapTM rProtein A column來純化此多株抗體,並進一步測定經初步純化之anti-FM2 之效價(titer)。本實驗工作首先成功合成出藥物與蛋白質之生物共軛物,其中將FM2與BSA之生物共軛物(FM2-BSA)當作免疫原(immunogen)進行小鼠免疫工作;另外,FM2與Ser之生物共軛物(FM2-Ser)當作酵素連結免疫吸附分析法(Enzyme-linked immunosorbent assay; ELIsA)檢測系統中所用之抗原(antigen),以避免測到腹水中之anti-BSA 抗體效價,而造成誤差。最後生產並初步純化出9.49mg/mL 多株抗體(含anti-FM2及anti-BSA),而後加以冷凍乾燥保存。
    The aim of this study was to synthosize flunitrazepam (FM2)-protein bioconjugates and produce polylonal antibodies (PAbs) against FM2 (anti-FM2 PAbs). ICR mice were intraperitoneally immunized with FM2-protein bioconjugates every two weeks. Because the rnolecular weight of FM2 is very small, it is difficult to induce antibodies production for mice. The FM2 molecules were conjugated with bovine serum albumin (BSA) and sericin (Ser), respectively Hyperimmune ICR mice produced anti-FM2 PAbs after injected with 0.5 mL pristane, and injected with NS-1 myeloma cells two weeks later. Ascites and serum were collected from ICR mice, but before the mice had difficulty moving, and anti-FM2 PAbs was purified by using HitrapTM rProtein A column. In this study, the drug-proteins bioconjugates had been successfully produced. FM2-BSA bioconjugate was as the immunogen for mice immunization and FM2-Ser bioconjugate was as the antigen for Enzyme-link Immunosorbent Assay ( ELISA ). Finally, the production and primary purification of anti-FM2 PAbs were performed. The concentration of PAbs obtained was 9.49mg/mL. Then , the anti-FM2 PAbs were stored by freeze-dry method.
    關聯: 嘉南學報(科技類)34期:p.86-97
    Appears in Collections:[嘉南學報] 34 期 (2008)
    [生物科技系(所)] 期刊論文
    [化妝品應用與管理系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    v34_86_97.pdf7875KbAdobe PDF341View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback